ALK and squamous cell lung carcinoma: Next generation sequencing guided treatment of &lt;i&gt;ALK&lt;/i&gt; tyrosine kinase inhibitor induced long survival in lung squamous cell carcinoma harboring &lt;i&gt;ROS1&lt;/i&gt; gene fusions: a case report and literature review.